Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-11T02:16:22.876Z Has data issue: false hasContentIssue false
  • English
  • Français

Controlled hypotension in adults undergoing choroidal melanoma resection: comparison between the efficacy of nitroprusside and magnesium sulphate

Published online by Cambridge University Press:  01 November 2008

M. Yosry  and
I. S. Othman
M. Yosry*
Affiliation:
Cairo University, Faculty of Medicine, Department of Anesthesiology, Cairo, Egypt
I. S. Othman
Affiliation:
Cairo University, Faculty of Medicine, Department of Ophthalmology, Cairo, Egypt
*
Correspondence to: Mohammad Yosry, 31 Meawen Street, East Omrania, Haram, Giza, 1st Floor, Flat Number 3, Post Code: 12551, Cairo, Egypt. E-mail: m_yosry_m@yahoo.com; Tel: +2 010 168 93 92; Fax: +2 02 7601348
Get access

Summary

Background and objective

To determine whether magnesium sulphate could induce controlled hypotension, reduce choroidal blood flow, provide a ‘dry’ operative field and could be compared with sodium nitroprusside in the recently raised issue of the use of hypotensive anaesthesia in eye surgery, i.e. for choroidal tumour surgery as the choroid is the most fragile and vascular structure in the eye.

Methods

Forty adult patients undergoing choroidal melanoma resection and anaesthetized with 2.5 mg kg−1 propofol, followed by a constant infusion of 120 μg kg−1 min−1, and remifentanil 1 μg kg−1, followed by a continuous infusion of 0.25 μg kg−1 min−1, were randomly assigned to two groups to receive either magnesium sulphate or sodium nitroprusside.

Results

Controlled hypotension was achieved at the target systolic pressure of 80 mmHg within 107 ± 16 and 69 ± 4.4 s for magnesium sulphate and sodium nitroprusside, respectively. Choroidal blood flow decreased by 24 ± 0.3% and 22 ± 3.3% for magnesium sulphate and sodium nitroprusside, respectively. Controlled hypotension was sustained in both groups throughout surgery, and the surgical field rating decreased in a range of 80% in both groups. Sodium nitroprusside decreased pH and increased PaCO2. There were no postoperative complications in any of the groups.

Conclusion

Magnesium sulphate controlled hypotension, reduced intraoperative pressure and provided good surgical conditions for choroidal melanoma resection with no need for additional use of a potent hypotensive agent in adults.

Keywords

SURGERY OPHTHALMICMAGNESIUM SULPHATESODIUM NITROPRUSSIDEHYPOTENSION CONTROLLEDCHOROID NEOPLASMS
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 25 , Issue 11 , November 2008 , pp. 891 - 896
Copyright
Copyright © European Society of Anaesthesiology 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Smith, C. Haemostasis in ear surgery. Proc R Soc Med 1971; 64: 1225–1226.Google Scholar
2.Saarnivaara, L, Brander, P. Comparison of three hypotensive anaesthetic methods for middle ear microsurgery. Acta Anaesthesiol Scand 1984; 28: 435–442.Google Scholar
3.Dietrich, GV, Heesen, M, Boldt, J, Hempelmann, G. Platelet function and adrenoceptors during and after induced hypotension using nitroprusside. Anesthesiology 1996; 85: 1334–1340.CrossRefGoogle ScholarPubMed
4.Pritchard, J. The use of the magnesium ion in the management of eclamptogenic toxemias. Surg Gynecol Obstet 1955; 100: 131–140.Google Scholar
5.Elsharnouby, N, Elsharnouby, M. Magnesium sulphate as a technique of hypotensive anaesthesia. Br J Anaesth 2006; 96: 727–731.CrossRefGoogle ScholarPubMed
6.Steinlechner, B, Dworschak, M, Birkenberg, B et al. Magnesium moderately decreases remifentanil dosage required for pain management after cardiac surgery. Br J Anaesth 2006; 96: 444–449.Google Scholar
7.Dubé, L, Granry, JC. The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review. Can J Anesth 2003; 50: 732–746.Google Scholar
8.Goutcher, CM, Cossar, DF, Ratnasabapathy, U, Burke, AM. Magnesium in the management of catecholamine-secreting glomus tumors with intracranial extension. Can J Anesth 2006; 53: 316–321.Google Scholar
9.Kroin, J, McCarthy, R, Von Roenn, N. Magnesium sulphate potentiates morphine antinociception at the spinal level. Anesth Analg 2000; 90: 913–917.Google Scholar
10.Buvanendran, A, McCarthy, RJ, Kroin, JS, Leong, W, Perry, P, Tuman, KJ. Intrathecal magnesium prolongs fentanyl analgesia: a prospective, randomized, controlled trial. Anesth Analg 2002; 95: 661–666.Google Scholar
11.Buerk, BM, Pulido, JS, Chiong, I et al. Vascular perfusion of choroidal melanoma by 3.0 tesla magnetic resonance imaging. Trans Am Ophthalmol Soc 2004; 102: 209–218.Google Scholar
12.Vlachakis, I, Gardikis, S, Michailoudi, E, Charissis, G. Treatment of haemangiomas in children using a Nd : YAG laser in conjunction with ice cooling of the epidermis: techniques and results. BMC Pediatr 2003; 3: 2 (available from http://www.biomedcentral.com/1471-2431/3/2).CrossRefGoogle Scholar
13.Augsburger, J, Corrêa, Z, Schneider, S et al. Diagnostic transvitreal fine-needle aspiration biopsy of small melanocytic choroidal tumors in nevus versus melanoma category. Trans Am Ophthalmol Soc 2002; 100: 225–234.Google Scholar
14.Fromme, GA, Mackenzie, RA, Gould, AB Jr, Lund, BA, Offord, KP. Controlled hypotension for orthognathic surgery. Anesth Analg 1986; 65: 683–686.Google Scholar
15.Degoute, CS, Ray, MJ, Manchon, M, Dubreuil, C, Banssillon, V. Remifentanil and controlled hypotension; comparison with nitroprusside or esmolol during tympanoplasty. Can J Anesth 2001; 48: 20–27.Google Scholar
16.Ornstein, E, Matteo, RS, Weinstein, JA, Schwartz, AE. A controlled trial of esmolol for the induction of deliberate hypotension. J Clin Anesth 1988; 1: 31–35.Google Scholar
17.Boezaart, A, Van der Merwe, J, Coetzee, A. Comparison of sodium nitroprusside and esmolol-induced controlled hypotension for functional endoscopic sinus surgery. Can J Anaesth 1995; 42: 373–376.Google Scholar
18.Pinaud, M, Souron, R, Lelausque, J, Gazeau, MF, Lajat, Y, Dixneuf, B. Cerebral blood flow and cerebral oxygen consumption during nitroprusside-induced hypotension to less than 50 mmHg. Anesthesiology 1989; 70: 255–260.CrossRefGoogle ScholarPubMed
19.Taylor, T, Styles, M, Lamming, A. Sodium nitroprusside as a hypotensive agent in general anaesthesia. Br J Anaesth 1970; 42: 859–864.CrossRefGoogle ScholarPubMed
20.Degoute, CS, Saumet, JL, Banssillon, V, Dittmar, A. Skin blood flow measured by thermal clearance method in anesthesia. Anesth Analg 1985; 64: 179–180.Google Scholar
21.Saumet, JL, Degoute, CS, Dittmar, A, Banssillon, V. Changes in skin thermal clearance during anaesthesia. Anaesthesia 1986; 41: 386–389.CrossRefGoogle ScholarPubMed
22.Saumet, JL, Leftheriotis, G, Dittmar, A, Delhomme, G, Degoutte, CS. Skin blood flow changes in anaesthetized humans: comparison between skin thermal clearance and finger pulse amplitude measurement. Eur J Appl Physiol Occup Physiol 1986; 54: 574–577.Google Scholar
23.Hayreh, S. Diabetic papillopathy and nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol 2002; 47: 600–602.CrossRefGoogle ScholarPubMed
24.Ornstein, E, Young, WL, Ostapkovich, N, Matteo, RS, Diaz, J. Deliberate hypotension in patients with intracranial arteriovenous malformations: esmolol compared with isoflurane and sodium nitroprusside. Anesth Analg 1991; 72: 639–644.Google Scholar
25.Ebert, T, Muzi, M, Berens, R, Goff, D, Kampine, JP. Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology 1992; 76: 725–733.Google Scholar